NCT06574048View on ClinicalTrials.gov

Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

July 31, 2027

Study Completion Date

January 31, 2028

Conditions
Carbon Monoxide PoisoningCarbon Monoxide IntoxicationCarbon Monoxide EncephalopathyCarbon Monoxide-induced Parkinsonism
Interventions
DRUG

saline placebo

IV saline bolus

DRUG

Dexamethasone

10mg IV Dexamethasone

Trial Locations (1)

68105

Nebraska Medicine, Hyperbaric Medicine Program, Clarkson Tower, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT06574048 - Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy | Biotech Hunter | Biotech Hunter